Asymchem Laboratories (002821)

Klein (stock code 002821) is a leading CDMO serving global pharmaceutical and biotechnology companies with more than 25 years of industry experience, 8 R&D and manufacturing sites, and 9,700 + employees (including 4,600 + R&D scientists). Its Chemical Macromolecules Division (CMMD) provides polypeptide CDMO services covering traditional polypeptides, pseudopeptides, peptide + linkers, peptide drug conjugates (PDCs), polymer-drug conjugates, and highly active peptide molecules. 400 + peptide project experience has been accumulated, which can produce linear/cyclic peptides of up to 40 amino acids (containing disulfide bonds, book peptides/thioether cyclic peptides), supports the SPPs/LPPS/heterozygous fragment strategy and modifications such as peg, lipidation, and N-methylation, and provides full-process GMP peptide production, release and stability research, and IND/NDA document support from preclinical to NDA declaration verification. The project covers GLP-1, antiviral, antibacterial, anti-tumor, macular degeneration and other fields. The company passed 65 + successful inspections by FDA, NMPA, TGA, MFDs, etc.

Asymchem Laboratories (002821)。